SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013156
Filing Date
2020-11-06
Accepted
2020-11-06 16:08:59
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20200930x10q.htm   iXBRL 10-Q 2170182
2 EX-31.1 tmb-20200930xex31d1.htm EX-31.1 15464
3 EX-31.2 tmb-20200930xex31d2.htm EX-31.2 13533
4 EX-32.1 tmb-20200930xex32d1.htm EX-32.1 7667
5 EX-32.2 tmb-20200930xex32d2.htm EX-32.2 7045
  Complete submission text file 0001558370-20-013156.txt   6991639

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20200930.xsd EX-101.SCH 46849
7 EX-101.CAL tmb-20200930_cal.xml EX-101.CAL 46316
8 EX-101.DEF tmb-20200930_def.xml EX-101.DEF 200058
9 EX-101.LAB tmb-20200930_lab.xml EX-101.LAB 353528
10 EX-101.PRE tmb-20200930_pre.xml EX-101.PRE 320679
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20200930x10q_htm.xml XML 1198195
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 201294484
SIC: 2834 Pharmaceutical Preparations